Cargando…
Promotion or Suppression of Murine Intestinal Polyp Development by iNKT Cell Directed Immunotherapy
The glycosphingolipid α-galactosylceramide (α-GalCer) is a well-described immune activator with strong anti-tumor properties in animal models. It is presented on CD1d and acts by stimulating the invariant, type I, natural killer T (iNKT) lymphocytes to rapidly secrete TH1 and TH2 associated cytokine...
Autores principales: | Wang, Ying, Sedimbi, Saikiran K., Löfbom, Linda, Besra, Gurdyal S., Porcelli, Steven A., Cardell, Susanna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405695/ https://www.ncbi.nlm.nih.gov/pubmed/30881361 http://dx.doi.org/10.3389/fimmu.2019.00352 |
Ejemplares similares
-
Unique invariant natural killer T cells promote intestinal polyps by suppressing TH1 immunity and promoting regulatory T cells
por: Wang, Ying, et al.
Publicado: (2017) -
Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses
por: Tripathi, Prabhanshu, et al.
Publicado: (2018) -
Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011) -
Non‐glycosidic compounds can stimulate both human and mouse iNKT cells
por: Jukes, John‐Paul, et al.
Publicado: (2016) -
Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells
por: Jimeno, Rebeca, et al.
Publicado: (2019)